What is the main business of Mitoterapia?

The main business activity of Mitoterapia focuses on other retail sale of food in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 3, 2019.

Where is the headquarters located?

The headquarters is located at: ul. Św. Marcina 19, 35-330 Rzeszów.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

The company reported a revenue of $438,899 in 2024, which is an increase of 2.6% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of $23,493, meaning the company increased its profit by 31.2%.

What is the largest operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $314,830 in 2024, representing 77% of all operating expenses.

Mitoterapiasp. z o.o.

Other retail sale of food in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2019-09-03

Share capital

5,000.00 PLN

Activity description

Mitoterapia offers consultations and autonomic nervous system assessments, including HRV testing, as well as mitochondrial supplements. Its products and services also include the TVNS-E device for non-invasive, transcutaneous vagus nerve stimulation and therapies supporting nervous system regulation.

Registered address

ul. św. Marcina 19, 35-330 Rzeszów, Poland

Website

mitoterapia.com

Phone

Social media

Electronic delivery address

AE:PL-71403-48918-VUHCW-26

Financials

Revenue history (in k)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 91 days for 2021), 1 not filed.

202523/06/2026
202410/07/2025
202316/07/2024
202215/07/2023
202114/10/2022
2020not filed

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 556.38kMedianUSD 177.27kAverageUSD 11.02m

Net profit

This companyUSD 12.58kMedianUSD 2.35kAverageUSD -29.24k

Operating costs

This companyUSD 541.59kMedianUSD 189.49kAverageUSD 11.10m

Assets

This companyUSD 86.07kMedianUSD 107.38kAverageUSD 6.50m

Industry

Offer

HRV testing
Health consultations
Mitochondrial therapies
Supplements
Therapeutic devices

Website technology

Online shop

WooCommerce

Website

WordPress

Contact and booking

HubSpot

Analytics and marketing

Google Analytics
Google Tag Manager

Trademarks

Mitoterapia holds 2 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2021.

Mark	Number	Classes	Status	Protected until
MITOTERAPIA(word)	Z.533801	5, 44	Protected	Sep 10, 2031
MitoDieta(word)	Z.533802	5, 44	Protected	Sep 10, 2031
MITOTERAPIA WSPARCIE MITOCHONDRIALNE	Z.533812	5, 44	Not registered	–

Mark	Protected until
MITOTERAPIA(word)	Sep 10, 2031
MitoDieta(word)	Sep 10, 2031
MITOTERAPIA WSPARCIE MITOCHONDRIALNE	–

Authorized Representatives

Dominika Helena Futyma – Management Board Member

Grzegorz Stanisław Futyma – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Dominika Helena Futymaage 46	40	$540.25	40%
Grzegorz Stanisław Futymaage 47	40	$540.25	40%
Szymon Piotr Futymaage 21	20	$270.12	20%

Dominika Helena Futyma, Grzegorz Stanisław Futyma and Szymon Piotr Futyma hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2019-09-13.

mBank
68 1140 2004 0000 3902 7916 8481

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $4,833.

Grant date	Purpose	Gross amount	Granting body
Jan 28, 2026	De minimis aid (in accordance with Commission Regulation 2023/2831)	$3,512$3,512	Prezes Banku Gospodarstwa Krajowego
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$13$13	Prezes Zakładu Ubezpieczeń Społecznych
Jun 8, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,282$1,282	STAROSTA POWIATU RZESZÓW

Competitors

	Name	Revenue	Website
	Wolfmedsp. z o.o. + limited partnership	$3,138,541.74	wolfmed.pl
	Atmis Suppliessp. z o.o.	$114,978.45	atmis.pl

Change history

Date	Event
2024-04-15	PKD change (Removed: 47.91; Added: 47.91.Z, 77.39.Z, 86.90.E)
2019-09-03	Entered in the register

FAQ

Last updated: 2026-06-23